Effects of Saffron Extract (Affron®) with 100 mg/kg and 200 mg/kg on Hypothalamic–Pituitary–Adrenal Axis and Stress Resilience in Chronic Mild Stress-Induced Depression in Wistar Rats

• Published in: Nutrients Vol. 15; no. 23; p. 4855
• Main Authors: Kim, Chae-Young, Ko, Kayoung, Choi, Seo-Hee, Jo, Miri, Kim, Jinhye, Yoon, Sunmi, Yi, Isaac Jinwon, Morán-Valero, María Inés, Kwon, Min-Young, Sohn, Johann, Yi, Sun-Shin
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 21.11.2023
• Subjects: Adaptation; animal models; Animals; Anxiety; Brain; Brain research; Brain-derived neurotrophic factor; Corticosterone; Food; Gene expression; Health aspects; Hypothalamus; Mental depression; Neuroplasticity; Oral administration; Physiological aspects; Physiology; Resilience (Psychology); saffron; Stress; Sucrose; South Korea; United States > US; saffron extract; stress resilience; Affron; unpredictable chronic mild stress; stress hormones; depression; hypothalamic–pituitary–adrenal axis; neuroplasticity
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15234855

Stress-related symptoms are a global concern, impacting millions of individuals, yet effective and safe treatments remain scarce. Although multiple studies have highlighted the stress- alleviating properties of saffron extract, the underlying mechanisms remain unclear. This study employs the unpredictable chronic mild stress (CMS) animal model to investigate the impact of a standardized saffron extract, Affron® (AFN), on hypothalamic–pituitary–adrenal (HPA) axis regulation and neuroplasticity in Wistar rats following repeated oral administration. The research evaluates AFN’s effects on various stress-related parameters, including hypothalamic gene expression, stress hormone levels, and the sucrose preference test. In animals subjected to continuous unpredictable CMS, repetitive administration of AFN at doses of 100 mg/kg and 200 mg/kg effectively normalized HPA axis dysregulation and enhanced neuroplasticity. Increased concentrations of AFN demonstrated greater efficacy. Following AFN oral administration, adrenocorticotropic and corticosterone hormone levels exhibited significant or nearly significant reductions in comparison to subjects exposed to stress only. These changes align with the alleviation of stress and the normalization of the HPA axis. These findings elucidate AFN’s role in stress mitigation, affirm its health benefits, validate its potential as a treatment for stress-related symptoms, confirm its physiological effectiveness, and emphasize its therapeutic promise.